Hint mode is switched on Switch off

Glenmark Pharmaceuticals, ordinary share
INE935A01035, GLENMARK

Add a stock to WL
Choose all Reset all
Glenmark Pharmaceuticals, сountry — India
No trading data
Data display in a chart | table
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
Source of information - PJSC "MOEX". Further disctribution of MOEX information is prohibited without prior consent with PJSC "MOEX".
from
to
ADD-IN
Cbonds add-in API
bond data api
Authorization required
You need to request access
More than 2,500 records have been found, please specify your request
No data for the selected period

Latest quotes

explore the most comprehensive database

800 000

bonds globally

Over 400

pricing sources

80 000

stocks

9 000

ETF

track your portfolio in the most efficient way
Bond Search
Watchlist
Excel ADD-IN
Get access
×

— Are you looking for the complete & verified bond data?

— We have everything you need:

full data on over 700 000 bonds, stocks & ETFs; powerful bond screener; over 350 pricing sources among stock exchanges & OTC market; ratings & financial reports; user-friendly interface; available anywhere via Website, Excel Add-in and Mobile app.

Register
×

Why

You will have detailed descriptive & pricing data for 650K bonds, 76K stocks, 8K ETFs
Get full access to the platform from any device & via Cbonds app
Enhance your portfolio management with Cbonds Excel Add-in
Build yield maps, make chart comparison within a click
Don't wait any longer — start using Cbonds today! Register

Issuer

Profile
Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. It manufactures and markets generic formulation products and active pharmaceutical ingredients (API), both in the domestic and international markets. In the formulation business, its business spans ...
Glenmark Pharmaceuticals is a pharmaceutical company headquartered in Mumbai, India. It manufactures and markets generic formulation products and active pharmaceutical ingredients (API), both in the domestic and international markets. In the formulation business, its business spans segments such as Dermatology, Internal Medicine, Paediatrics, Gynaecology, ENT and Diabetes.
Show more Hide
  • Issuer
  • Full borrower / issuer name
    Glenmark Pharmaceuticals Ltd
  • Industry
    Pharmaceutical Preparation and Biotechnology

Indicators

News

14/03/2024 S&P Global Ratings upgrades Foreign Currency LT credit rating of Glenmark Pharmaceuticals to "BB+" from "BB"; outlook stable
14/03/2024 S&P Global Ratings upgrades Local Currency LT credit rating of Glenmark Pharmaceuticals to "BB+" from "BB"; outlook stable
05/10/2023 Fitch Ratings affirms Glenmark Pharmaceuticals at "BB" (LT Int. Scale (foreign curr.) credit rating); outlook stable
04/10/2023 Fitch Affirms Glenmark Pharmaceuticals at 'BB'; Outlook Stable (Rating action commentary)
03/10/2023 S&P: Glenmark Pharmaceuticals Outlook Revised To Positive On Proposed GLS Stake Sale; 'BB' Rating Affirmed (Rating action commentary)
All organization news

Holders

Industry Leaders

Registration is required to get access.